文献速递神经技术与安全PET

通过深度学习从低剂量数据恢复三维全剂量脑部PET体积:定量评估与临床评价

3D full-dose brain-PET volume recovery from low-dose data through deep learning: quantitative assessment and clinical evaluation.
PubMed 文献 · Eur Radiol · 2024-11-28

本研究对456名参与者分别使用三种不同PET扫描仪和两种不同示踪剂进行回顾性研究,提出空间感知降噪网络(SANR)深度学习法从低剂量数据恢复三维全剂量PET体积。SANR病灶检测准确率95.3%(95%CI:90.1%,100%),参考全剂量PET为98.4%(95%CI:95.4%,100%);在阿尔茨海默病诊断中两者准确率相同。结论认为SANR降噪的低剂量PET显著降低示踪剂剂量,在脑病灶检测和阿尔茨海默病诊断方面显示非劣效诊断性能。

要点

  • SANR从低剂量PET恢复的全剂量体积病灶检测准确率95.3%,参考全剂量PET为98.4%。
  • 在阿尔茨海默病诊断中,SANR恢复体积与参考全剂量PET准确率相同。
  • SANR与二维深度学习法在图像质量指标上差异有统计学意义(p<0.05)。

核心结论

  • 与参考全剂量PET相比,所提出方法降噪的低剂量PET显著降低示踪剂剂量,在脑病灶检测和阿尔茨海默病诊断中显示非劣效诊断性能。

研究设计与样本

  • 回顾性研究,纳入456名参与者,分别使用三种不同PET扫描仪和两种不同示踪剂扫描。
  • 提出空间感知降噪网络(SANR)深度学习法,从低剂量数据恢复三维全剂量PET体积。
  • 以常规全剂量PET体积为参考,将SANR与二维深度学习法进行比较。
  • 采用Wilcoxon符号秩检验比较不同深度学习降噪方法的图像质量指标。
  • 由两名核医学医师采用5分评分方案(5分为优)检查恢复的全剂量PET体积,并对诊断质量给出二分类判定(阴性或阳性)。

诊断标准与关键数值

  • SANR病灶检测准确率95.3%(95%CI:90.1%,100%),参考全剂量PET病灶检测准确率98.4%(95%CI:95.4%,100%)。
  • 阿尔茨海默病诊断中,参考全剂量PET与SANR恢复的全剂量PET准确率相同。
  • 临床评价采用5分评分方案,5分为优。
  • 诊断质量评估采用二分类判定(阴性或阳性)。

临床应用与阅片要点

  • 所提出方法可能增强低示踪剂剂量下PET扫描的效用,尤其适用于需要多次检查的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Low-dose (LD) PET imaging would lead to reduced image quality and diagnostic efficacy. We propose a deep learning (DL) method to reduce radiotracer dosage for PET studies while maintaining diagnostic quality.

METHODS: This retrospective study was performed on 456 participants respectively scanned by three different PET scanners with two different tracers. A DL method called spatially aware noise reduction network (SANR) was proposed to recover 3D full-dose (FD) PET volumes from LD data. The performance of SANR was compared with a 2D DL method taking regular FD PET volumes as the reference. Wilcoxon signed-rank test was conducted to compare the image quality metrics across different DL denoising methods. For clinical evaluation, two nuclear medicine physicians examined the recovered FD PET volumes using a 5-point grading scheme (5 = excellent) and gave a binary decision (negative or positive) for diagnostic quality assessment.

RESULTS: Statistically significant differences (p < 0.05) were found in terms of image quality metrics when SANR was compared with the 2D DL method. For clinical evaluation, SANR achieved a lesion detection accuracy of 95.3% (95% CI: 90.1%, 100%), while the reference full-dose PET volumes obtained a lesion detection accuracy of 98.4% (95% CI: 95.4%, 100%). In Alzheimer's disease diagnosis, both the reference FD PET volumes and the FD PET volumes recovered by SANR exhibited the same accuracy.

CONCLUSION: Compared with reference FD PET, LD PET denoised by the proposed approach significantly reduced radiotracer dosage and showed noninferior diagnostic performance in brain lesion detection and Alzheimer's disease diagnosis.

KEY POINTS: Question The current trend in PET imaging is to reduce injected dosage, which leads to low-quality PET images and reduces diagnostic efficacy. Findings The proposed deep learning method could recover diagnostic quality PET images from data acquired with a markedly reduced radiotracer dosage. Clinical relevance The proposed method would enhance the utility of PET scanning at lower radiotracer dosage and inform future workflows for brain lesion detection and Alzheimer's disease diagnosis, especially for those patients who need multiple examinations.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Guo R, Wang J, Miao Y, et al. 3D full-dose brain-PET volume recovery from low-dose data through deep learning: quantitative assessment and clinical evaluation. Eur Radiol. 2024. PMID: 39609283. doi:10.1007/s00330-024-11225-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。